论文部分内容阅读
目的观察经(鼻)面罩双水平气道正压通气(BIPAP)治疗慢性阻塞性肺疾病(COPD)急性加重并呼吸衰竭的治疗作用。方法经BIPAP通气治疗的85例患者为治疗组,同期常规方法治疗的85例患者为对照组,比较两组治疗前后血气分析指标及临床改善情况。结果治疗组经无创正压通气治疗后血气指标及一般情况明显改善;对照组较前有改善,但较治疗组差异有显著性。治疗组住院天数较对照组明显缩短(P<0.05)。结论BIPAP呼吸机经(鼻)面罩无创通气治疗COPD并呼吸衰竭,疗效满意,无明显并发症,值得临床推广应用。
Objective To observe the therapeutic effect of nasal mask bi-level positive airway pressure (BIPAP) on acute exacerbation of chronic obstructive pulmonary disease (COPD) and respiratory failure. Methods Eighty-five patients treated by BIPAP ventilation were treated, and 85 patients treated by conventional method were compared. Blood gas analysis and clinical improvement were compared between the two groups before and after treatment. Results After treatment with non-invasive positive pressure ventilation, the blood gas indexes and general conditions in the treatment group were significantly improved. The control group improved compared with the previous group, but the difference was significant compared with the treatment group. The days of hospitalization in the treatment group were significantly shorter than those in the control group (P <0.05). Conclusion BIPAP ventilator via nasal mask noninvasive ventilation in the treatment of COPD and respiratory failure, with satisfactory results, no obvious complications, worthy of clinical application.